UnitedHealth Group (NYSE:UNH) Given New $600.00 Price Target at Piper Sandler

UnitedHealth Group (NYSE:UNH) had its price target reduced by Piper Sandler from $605.00 to $600.00 in a report released on Thursday,Benzinga reports. They currently have an overweight rating on the healthcare conglomerate’s stock.

A number of other research analysts also recently issued reports on UNH. Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Royal Bank of Canada reduced their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. KeyCorp started coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price for the company. HSBC downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, Barclays boosted their price target on UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a report on Wednesday, November 27th. Three research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $628.37.

UnitedHealth Group Trading Down 0.3 %

UnitedHealth Group stock opened at $504.51 on Thursday. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $464.29 billion, a P/E ratio of 32.87, a P/E/G ratio of 1.53 and a beta of 0.58. The business has a 50-day simple moving average of $561.99 and a two-hundred day simple moving average of $560.42. UnitedHealth Group has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter last year, the company posted $6.56 EPS. The company’s revenue was up 9.2% compared to the same quarter last year. Analysts predict that UnitedHealth Group will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.66%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Institutional Trading of UnitedHealth Group

Institutional investors have recently bought and sold shares of the stock. SK Wealth Management LLC purchased a new position in shares of UnitedHealth Group during the 3rd quarter worth about $351,000. Independent Solutions Wealth Management LLC boosted its position in shares of UnitedHealth Group by 2.0% during the third quarter. Independent Solutions Wealth Management LLC now owns 2,067 shares of the healthcare conglomerate’s stock valued at $1,209,000 after buying an additional 41 shares during the period. IMS Capital Management raised its holdings in shares of UnitedHealth Group by 0.7% in the third quarter. IMS Capital Management now owns 3,626 shares of the healthcare conglomerate’s stock worth $2,120,000 after buying an additional 25 shares during the period. Lord Abbett & CO. LLC grew its position in UnitedHealth Group by 29.1% in the 3rd quarter. Lord Abbett & CO. LLC now owns 783,143 shares of the healthcare conglomerate’s stock valued at $457,888,000 after acquiring an additional 176,543 shares during the last quarter. Finally, 1ST Source Bank lifted its position in shares of UnitedHealth Group by 5.6% during the third quarter. 1ST Source Bank now owns 1,687 shares of the healthcare conglomerate’s stock worth $986,000 after purchasing an additional 90 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.